New to 2014, we the launch of Deschloroetizolam, another benzodiazepine compound likely to be one of the most popular due to it being an analogue of Etizolam. Strictly called a thienodiazepine, preliminary hypotheses predict that this novel chemical should maintain many of the same physiological actions as Etizolam, with a possible faster onset of action and longer half-life. However, based on the previous chemical relationship seen between triazolam and alprazolam, it may be 0.5 the potency of Etizolam; in protein binding affinity. Just like other compounds within this class, Deschloroetizolam will undoubtedly cause sedation, muscle relaxant, anxiolytic and anti-convulsant properties should this chemical reach any form of in-vivo testing. For the moment, however, all studies conducted are strictly in-vitro (outside living organism), using mainly cell cultures and chemical analysis techniques to properly ascertain a possible therapeutic future for the compound.